An agenda built through deep collaboration with our community to ensure every session delivers substance over soundbites. You’ll hear from true subject matter leaders via candid case studies, collaborative panels, and varied panel discussions —providing clarity on what’s driving success across the customer engagement landscape
- Reimagine commercialization with commercial, medical affairs and market access collaboration across an asset's lifecycle, with customer insights shaping decisions from the earliest stages
- Drive industry-leading customer engagement by combining organizational integration and agility with AI-powered personalization for a seamless experience that meets every customer where they are, ultimately ensuring innovations reach and benefit patients faster with greater impact
- Learn how two sales leaders built trust and drove adoption across their teams, from recruiting the right pilot champions to scaling AI into everyday practice
- Discover how AI-generated interaction insights are reshaping self-development, giving reps a clearer, more objective path to what's driving HCP behavior change
- See how organizations are using APEX* Pharma Sentiment Score to inform strategy in real-time, driving continuous improvement all while being able to benchmark against industry peers.
*ADVANCE AI Pharma Emotive IndeX
Â
Ryan Beaird, Senior Area General Manager, Bayer
Deanna Olson, Senior Area General Manager, Bayer
- Redefine customer interactions by shifting from rigid CRM journeys to intelligent platforms that adapt dynamically to context, timing, and intentÂ
- Drive commercial growth through AI segmentation capabilities that anticipate patient journeys and predict prescribing patterns before they occurÂ
Alicia Abella, Head of AI Product, Novo Nordisk
Darshan Joshi, Head of Commercial Technology Blueprint Transformation, USBU & OBU, Tadeka
Elizabeth Beringer, President, Real ChemistryÂ
- Strengthen patient relationships by shifting from channel-level fixes to a true operating model
- Maximize direct-to-patient value by treating this as a systems design challenge, not a content or technology gap
- Close the gap between initiatives that look strong on day one and models built to hold up as direct-to-patient relationships scale
Â
Silvi Haldipur, Head of Customer Experience Strategy and Human Centered Design, Novo Nordisk
Amy Turnquist, VP, the America's Operating Borad, Healthcare Businesswomen’s Association
 From prescription to patient journey: Orchestrate end-to-end value through data, technology and cross-functional alignmentÂ
- Deploy RWE and patient-outcomes data to reframe HCP perception, proving holistic care impact beyond clinical endpoints
- Equip MSLs, reps, and brand teams with role-specific, data-powered playbooks to deliver a unified value narrative across home care, decentralized diagnostics, reimbursement, and access
- Leverage data platforms to transform everyday patient behavior into commercial-ready evidence that bridges trial endpoints and lived experience
Â
Saket Malhotra, Global Head of Commercial Digital, BioMarin
Holly Valdiviez, Senior Vice President, Neuropsychiatry Franchise, Acadia Pharmaceuticals
Caroline De Marco, VP, Population Health Community Impact Ambassador, Genentech
- Discover how the Giants built a cross-channel customer feedback engine that informs strategy in real time, improving content from week to week in one of the NFLs biggest media markets
- Hear how the Giants build customer experiences that compete with entertainment, social media, and every other thing pulling for attention, and what that means for the modern HCP
David Dominik, Vice President, Digital Strategy, New York Football Giants
- The blind spot in HCP targeting: Most targeting models are built on retrospective claims analysis — a record of where patients ended up, not how they actually experienced their disease. We'll examine why this backward-looking approach systematically misdirects commercial strategy.
- Clinical intent as the missing layer: Introducing clinical intent — a more holistic way to read disease experience and identify the right patient cohort before asking which HCPs to target, rather than reverse-engineering targeting from historical claims patterns.
- Operationalizing Patient First, Doctor Second: What this reordering means in practice — for data strategy, cohort definition, and how commercial teams should rethink the sequence of who they study first.
Scott Phillips, Vice President, Real World Data Diaceutics, Diaceutics
- Deliver more relevant customer interactions by deploying tailored engagement models that address specific needs across diverse segments
- Maximize reach and impact by implementing flexible frameworks that adapt to varying stakeholder levels
Johanna Rossell, SVP, General Manager, Regenerative Medicine, Sumitomo Pharma America
Brenden Schultek, VP of Sales, Merz Therapeutics
Moderator: Mike Zapiec, Consulting Executive, Inizio Ignite
- Harness agentic AI, from everyday workflows to strategy formulation, to sharpen the commercial decisions that drive revenue growth, launch speed, and sales force productivity
- Extend AI beyond commercial performance into market access and patient impact, turning cross-functional insights into stronger access strategies and outcomes that matter to patients
Izumi Yoshida, Executive Officer, Head of Pharma, GenerativeX
Interactive workshop 2: From siloed to seamless: How data connectivity unlocks the real-world consumer, patient, and HCP journey
- Healthcare and pharma marketers have more data than ever — yet the consumer, patient, and HCP journey often remains fragmented across disconnected 1st, 2nd, and 3rd-party sources
- This session explores how data connectivity, not just data volume, is the key to overcoming that fragmentation
- Attendees will learn how securely linking owned, partner, and external data sources creates a unified, longitudinal view of the journey — from awareness through diagnosis, treatment, and prescribing behavior
- The discussion will cover what effective data connectivity requires in practice, and how organizations can translate a connected view into sharper targeting, better measurement, and superior real-world business outcomes
Â
Jason Brenner, RVP, Healthcare & Life Sciences, LiveRamp
- Accelerate strategic decisions by deploying AI analytics that filter out distractions and spotlight the precise signals forecasting HCP engagement quality and conversion opportunitiesÂ
- Amplify cross-functional collaboration by creating unified data architectures that transform disconnected touchpoints into one continuously updated view of the complete customer journeyÂ
- Eliminate the revision cycles that stall your commercial and medical teams through screening tools that cut approval timelines and get personalised content into the hands of field teams fasterÂ
- Build tiered approval frameworks that apply the right level of scrutiny to the right content, empowering your team to scale personalised, compliant customer engagement without the bottlenecks that slow impact
- Elevate engagement quality by fusing NBA precision with value-driven content strategies that address real customer priorities instead of relying solely on channel optimizationÂ
- Drive operational excellence by integrating omnichannel delivery, AI MLR acceleration and tiered approval systems into one cohesive personalization engine that scales impactÂ
Nivi Mogali, Director, Enterprise Omnichannel Analytics Capabilities, GSK
Vijay Iyengar, Executive Director, Global Digital Business Transformation: Sales, Marketing & Enterprise Strategy, Eisai
Jorge Herrera, Senior Director, Omnichannel Engagement US, CSL
Erin Gallagher, Principal, Customer Success, Veeva Ostro
- Elevate engagement quality by fusing NBA precision with value-driven content strategies that address real customer priorities instead of relying solely on channel optimizationÂ
- Drive operational excellence by integrating omnichannel delivery, AI MLR acceleration and tiered approval systems into one cohesive personalization engine that scales impactÂ
- Map the structural parallels between underrepresented leadership pathways in pharma and underrepresented customer voices in the healthcare ecosystem — identifying the shared patterns of "fewer peers, fewer channels, more friction"
- Translate personal leadership strategies — built from navigating rooms with limited access or sponsorship — into concrete tactics for building trust and influence with underserved HCP and patient populations
- Co-create at least one practical, cross-functional approach (commercial, medical, or engagement) that teams can pilot to authentically reach a specific underrepresented HCP or patient segment
- Commit to a personal or team-level action step — walking away with both a peer network and a concrete next move to bring back to their organization
- Accelerate time-to-market for symposia content and capture HCP attention at the moment of highest engagement by producing targeted educational resources within days of data readoutsÂ
- Strengthen HCP relationships and boost engagement with relevant, compelling content at the exact moment it matters mostÂ
- Explore the forces that turned GLP-1 market into a blueprint for consumer-driven healthcare
- Identify the implications for commercial leaders as the lessons from the GLP-1 market reshape forecasting, value propositions, customer engagement, and future launch strategies
Chareen Lim, Senior Vice President, Ipsos
-Detect emerging adoption barriers early with real-world data, and act on the signals before they derail intervention outcomes
-Strengthen adherence results by deploying agile measurement systems that trigger immediate program adjustments based on behavioral data
Wes Little, Chief Analytics & Data Officer, GM, Wellsky
Matt Wilson, Founder and CEO, uMed
- Accelerate decision-making by delivering on-demand, real-time analytics that enable medical and commercial teams to act faster without waiting for manual data requests or approvals
- Drive measurable business outcomes by translating shared insights into automated workflows that reduce time-to-action and improve consistency across functions
Anindita Sinha, VP, Commercial Operations, Shionogi
Preethi Ramesh, Director - Data Digital & Technology, Takeda
Philip Poulidis, CEO & Co-Founder, ODAIA
- Drive strategic alignment by leveraging AI-powered intelligence layers that grant appropriate visibility to medical and commercial teams while respecting access protocols
- Optimize cross-functional performance by building data-sharing frameworks that eliminate silos without breaching regulatory separation requirements
Is your DTC strategy strengthening patient engagement, or creating a new disconnect in the healthcare journey?
- Unlock the direct-to-consumer opportunity: Learn how leading pharma organizations are building trusted, personalized patient relationships beyond traditional HCP engagement models through digital, telehealth, and direct-to-patient ecosystems.
- Turn consumer engagement into measurable impact: Discover how to connect consumer data, patient experience, access, and adherence strategies to drive faster therapy initiation, improved outcomes, and sustainable commercial growth.
- Accelerate organizational performance by embedding AI-enabled tools and role-specific intelligence that empower teams to scale meaningful, compliance-ready HCP engagement Â
- Build hybrid team structures that blend human expertise with agentic AI to scale consistent, outcome-led personalization across every HCP touchpointÂ
Rachel Aldana, Head of Strategy, International BU Marketing & Commercial Excellence, Takeda
Michael Sobotka, VP, Data Science - Global Commercial Analytics, Pfizer
Robert (Bob) Allen, Head, Omnichannel Strategy & Digital Transformation, Global Public Affairs, Gilead Sciences
Moderator: Gaurav Jaggi, Senior Director, Insights & Analytics, Regeneron
Pharma executives take the stage to define their biggest unsolved challenges and describe the perfect solution — if it existed. An open, on-stage session where end users set the agenda and solution providers listen. The ideal close after two days of content: reflect, identify the gaps, and look ahead.
- Define the right AI foundation by aligning architecture, investment priorities, and resource allocation to accelerate business value
- Establish scalable systems, governance, and operating models that enable organizations to move from pilots to enterprise-wide adoption
- Identify the most critical unmet challenges and explore how emerging technologies can close gaps and unlock future growth
Jaspreet Singh, Chief Customer Officer, Empower Pharmacy
Div Khetia, Vice President, Medical Affairs Channel Excellence and Medical Digital Health Solutions, Pfizer
- Reimagine commercialization with commercial, medical affairs and market access collaboration across an asset's lifecycle, with customer insights shaping decisions from the earliest stages
- Drive industry-leading customer engagement by combining organizational integration and agility with AI-powered personalization for a seamless experience that meets every customer where they are, ultimately ensuring innovations reach and benefit patients faster with greater impact
- Learn how two sales leaders built trust and drove adoption across their teams, from recruiting the right pilot champions to scaling AI into everyday practice
- Discover how AI-generated interaction insights are reshaping self-development, giving reps a clearer, more objective path to what's driving HCP behavior change
- See how organizations are using APEX* Pharma Sentiment Score to inform strategy in real-time, driving continuous improvement all while being able to benchmark against industry peers.
*ADVANCE AI Pharma Emotive IndeX
Â
Ryan Beaird, Senior Area General Manager, Bayer
Deanna Olson, Senior Area General Manager, Bayer
- Redefine customer interactions by shifting from rigid CRM journeys to intelligent platforms that adapt dynamically to context, timing, and intentÂ
- Drive commercial growth through AI segmentation capabilities that anticipate patient journeys and predict prescribing patterns before they occurÂ
Alicia Abella, Head of AI Product, Novo Nordisk
Darshan Joshi, Head of Commercial Technology Blueprint Transformation, USBU & OBU, Tadeka
Elizabeth Beringer, President, Real ChemistryÂ
- Strengthen patient relationships by shifting from channel-level fixes to a true operating model
- Maximize direct-to-patient value by treating this as a systems design challenge, not a content or technology gap
- Close the gap between initiatives that look strong on day one and models built to hold up as direct-to-patient relationships scale
Â
Silvi Haldipur, Head of Customer Experience Strategy and Human Centered Design, Novo Nordisk
Amy Turnquist, VP, the America's Operating Borad, Healthcare Businesswomen’s Association
 From prescription to patient journey: Orchestrate end-to-end value through data, technology and cross-functional alignment
- Deploy RWE and patient-outcomes data to reframe HCP perception, proving holistic care impact beyond clinical endpoints
- Equip MSLs, reps, and brand teams with role-specific, data-powered playbooks to deliver a unified value narrative across home care, decentralized diagnostics, reimbursement, and access
- Leverage data platforms to transform everyday patient behavior into commercial-ready evidence that bridges trial endpoints and lived experience
Saket Malhotra, Global Head of Commercial Digital, BioMarin
Holly Valdiviez, Senior Vice President, Neuropsychiatry Franchise, Acadia Pharmaceuticals
Caroline De Marco, VP, Population Health Community Impact Ambassador, Genentech
- Discover how the Giants built a cross-channel customer feedback engine that informs strategy in real time, improving content from week to week in one of the NFLs biggest media markets
- Hear how the Giants build customer experiences that compete with entertainment, social media, and every other thing pulling for attention, and what that means for the modern HCP
David Dominik, Vice President, Digital Strategy, New York Football Giants
- Accelerate organizational performance by embedding AI-enabled tools and role-specific intelligence that empower teams to scale meaningful, compliance-ready HCP engagement Â
- Build hybrid team structures that blend human expertise with agentic AI to scale consistent, outcome-led personalization across every HCP touchpointÂ
Rachel Aldana, Head of Strategy, International BU Marketing & Commercial Excellence, Takeda
Michael Sobotka, VP, Data Science - Global Commercial Analytics, Pfizer
Robert (Bob) Allen, Head, Omnichannel Strategy & Digital Transformation, Global Public Affairs, Gilead Sciences
Moderator: Gaurav Jaggi, Senior Director, Insights & Analytics, Regeneron
Pharma executives take the stage to define their biggest unsolved challenges and describe the perfect solution — if it existed. An open, on-stage session where end users set the agenda and solution providers listen. The ideal close after two days of content: reflect, identify the gaps, and look ahead.
Â
- Define the right AI foundation by aligning architecture, investment priorities, and resource allocation to accelerate business value
- Establish scalable systems, governance, and operating models that enable organizations to move from pilots to enterprise-wide adoption
- Identify the most critical unmet challenges and explore how emerging technologies can close gaps and unlock future growth
Â
Jaspreet Singh, Chief Customer Officer, Empower Pharmacy
Div Khetia, Vice President, Medical Affairs Channel Excellence and Medical Digital Health Solutions, Pfizer
- Strengthen precision targeting by shifting from assumed to observed HCP behaviors through foundational data capabilitiesÂ
- Prove field impact by translating AI-driven NBA recommendations into actionable engagement strategies
Â
Akash Jain, Director, Data & Analytics Strategy (US Oncology), Merck
- Accelerate strategic decisions by deploying AI analytics that filter out distractions and spotlight the precise signals forecasting HCP engagement quality and conversion opportunitiesÂ
- Amplify cross-functional collaboration by creating unified data architectures that transform disconnected touchpoints into one continuously updated view of the complete customer journeyÂ
- Accelerate time-to-market for symposia content and capture HCP attention at the moment of highest engagement by producing targeted educational resources within days of data readoutsÂ
- Strengthen HCP relationships and boost engagement with relevant, compelling content at the exact moment it matters most
- Explore the forces that turned GLP-1 market into a blueprint for consumer-driven healthcare
- Identify the implications for commercial leaders as the lessons from the GLP-1 market reshape forecasting, value propositions, customer engagement, and future launch strategies
Chareen Lim, Senior Vice President, Ipsos
- Accelerate decision-making by delivering on-demand, real-time analytics that enable medical and commercial teams to act faster without waiting for manual data requests or approvals
- Drive measurable business outcomes by translating shared insights into automated workflows that reduce time-to-action and improve consistency across functions
Â
Anindita Sinha, VP, Commercial Operations, Shionogi
Preethi Ramesh, Director - Data Digital & Technology, Takeda
Philip Poulidis, CEO & Co-Founder, ODAIA
- Elevate engagement quality by fusing NBA precision with value-driven content strategies that address real customer priorities instead of relying solely on channel optimizationÂ
- Drive operational excellence by integrating omnichannel delivery, AI MLR acceleration and tiered approval systems into one cohesive personalization engine that scales impactÂ
Â
Nivi Mogali, Director, Enterprise Omnichannel Analytics Capabilities, GSK
Vijay Iyengar, Executive Director, Global Digital Business Transformation: Sales, Marketing & Enterprise Strategy, Eisai
Jorge Herrera, Senior Director, Omnichannel Engagement US, CSL
Erin Gallagher, Principal, Customer Success, Veeva Ostro
- The blind spot in HCP targeting: Most targeting models are built on retrospective claims analysis — a record of where patients ended up, not how they actually experienced their disease. We'll examine why this backward-looking approach systematically misdirects commercial strategy.
- Clinical intent as the missing layer: Introducing clinical intent — a more holistic way to read disease experience and identify the right patient cohort before asking which HCPs to target, rather than reverse-engineering targeting from historical claims patterns.
- Operationalizing Patient First, Doctor Second: What this reordering means in practice — for data strategy, cohort definition, and how commercial teams should rethink the sequence of who they study first.
Â
Scott Phillips, Vice President, Real World Data Diaceutics, Diaceutics
- Deliver more relevant customer interactions by deploying tailored engagement models that address specific needs across diverse segments
- Maximize reach and impact by implementing flexible frameworks that adapt to varying stakeholder levels
Â
Johanna Rossell, SVP, General Manager, Regenerative Medicine, Sumitomo Pharma America
Brenden Schultek, VP of Sales, Merz Therapeutics
Moderator: Mike Zapiec, Consulting Executive, Inizio Ignite
- Eliminate the revision cycles that stall your commercial and medical teams through screening tools that cut approval timelines and get personalised content into the hands of field teams fasterÂ
- Build tiered approval frameworks that apply the right level of scrutiny to the right content, empowering your team to scale personalised, compliant customer engagement without the bottlenecks that slow impact
- Elevate engagement quality by fusing NBA precision with value-driven content strategies that address real customer priorities instead of relying solely on channel optimizationÂ
- Drive operational excellence by integrating omnichannel delivery, AI MLR acceleration and tiered approval systems into one cohesive personalization engine that scales impactÂ
-Detect emerging adoption barriers early with real-world data, and act on the signals before they derail intervention outcomes
-Strengthen adherence results by deploying agile measurement systems that trigger immediate program adjustments based on behavioral data
Â
Wes Little, Chief Analytics & Data Officer, GM, Wellsky
Matt Wilson, Founder and CEO, uMed
- Drive strategic alignment by leveraging AI-powered intelligence layers that grant appropriate visibility to medical and commercial teams while respecting access protocols
- Optimize cross-functional performance by building data-sharing frameworks that eliminate silos without breaching regulatory separation requirements
- Harness agentic AI, from everyday workflows to strategy formulation, to sharpen the commercial decisions that drive revenue growth, launch speed, and sales force productivity
- Extend AI beyond commercial performance into market access and patient impact, turning cross-functional insights into stronger access strategies and outcomes that matter to patients
Â
Izumi Yoshida, Executive Officer, Head of Pharma, GenerativeX
Interactive workshop 2: From siloed to seamless: How data connectivity unlocks the real-world consumer, patient, and HCP journey
- Healthcare and pharma marketers have more data than ever — yet the consumer, patient, and HCP journey often remains fragmented across disconnected 1st, 2nd, and 3rd-party sources
- This session explores how data connectivity, not just data volume, is the key to overcoming that fragmentation
- Attendees will learn how securely linking owned, partner, and external data sources creates a unified, longitudinal view of the journey — from awareness through diagnosis, treatment, and prescribing behavior
- The discussion will cover what effective data connectivity requires in practice, and how organizations can translate a connected view into sharper targeting, better measurement, and superior real-world business outcomes
Jason Brenner, RVP, Healthcare & Life Sciences, LiveRamp
- Map the structural parallels between underrepresented leadership pathways in pharma and underrepresented customer voices in the healthcare ecosystem — identifying the shared patterns of "fewer peers, fewer channels, more friction"
- Translate personal leadership strategies — built from navigating rooms with limited access or sponsorship — into concrete tactics for building trust and influence with underserved HCP and patient populations
- Co-create at least one practical, cross-functional approach (commercial, medical, or engagement) that teams can pilot to authentically reach a specific underrepresented HCP or patient segment
- Commit to a personal or team-level action step — walking away with both a peer network and a concrete next move to bring back to their organization
Is your DTC strategy strengthening patient engagement, or creating a new disconnect in the healthcare journey?
- Unlock the direct-to-consumer opportunity: Learn how leading pharma organizations are building trusted, personalized patient relationships beyond traditional HCP engagement models through digital, telehealth, and direct-to-patient ecosystems.
- Turn consumer engagement into measurable impact: Discover how to connect consumer data, patient experience, access, and adherence strategies to drive faster therapy initiation, improved outcomes, and sustainable commercial growth.
